Company intelligence
DH Nordic ApS
Strategic Partnerships and Business Development for the Pharmaceutical Industry.
About DH Nordic ApS
About DH Nordic ApS DH Nordic ApS is a specialised pharmaceutical business development partner connecting companies across Europe through product sourcing, in-licensing and out-licensing, and strategic portfolio expansion. At the centre of DH Nordic is a continuously growing database of pharmaceutical product opportunities — aggregating dossiers, product offers, and portfolio assets from partners worldwide. This enables faster, more targeted identification of licensing opportunities and commercial partnerships across both generics and specialty pharmaceuticals. DH Nordic serves as a dedicated hub between companies seeking to expand their product portfolios and companies looking to commercialise their assets in European markets. By consolidating supply-side opportunities with market demand, DH Nordic accelerates partnership creation and unlocks portfolio value on both sides of the deal. What DH Nordic offers: ✔ Pharmaceutical product sourcing and portfolio screening ✔ In-licensing and out-licensing opportunity identification ✔ Commercial and development partner matching ✔ Strategic portfolio and market expansion advisory ✔ Business development project support ✔ Interim BD and licensing support Whether you are an emerging company entering European markets or an established player looking to grow your pipeline, DH Nordic brings the network, the database, and the expertise to move faster. Pharmaceutical companies are welcome to share product lists or portfolio opportunities to increase visibility toward potential European partners. 📩 Interested in licensing opportunities, product sourcing, or a strategic BD conversation? Reach out directly — we'd be glad to explore how we can work together.
Verified activity
Signals from DH Nordic ApS
2 published signals
Products
DH Nordic ApS announced that Bilastine Oral Solution 2.5 mg/mL, a paediatric formulation referencing Bilaxten, is ready for submission Q1 2027.
Reported by DH Nordic ApS
Partnerships
DH Nordic ApS signed an exclusive representation agreement with a pharmaceutical manufacturer to expand its out-licensing portfolio across Europe.
Reported by DH Nordic ApS